Back
Galmed Pharmaceuticals Vs. Corcept Therapeutics Industry Stock Comparison
Sell
5
GLMD
Galmed Pharmaceuticals
Last Price:
3.10
Seasonality Move:
12.06%
Buy
86
CORT
Corcept Therapeutics
Last Price:
57.76
Seasonality Move:
4.71%
Sell
5
Galmed Pharmaceuticals (GLMD)
is a Sell
Is Galmed Pharmaceuticals a Buy, Sell or Hold?
- The current Galmed Pharmaceuticals [GLMD] share price is $2.88. The Score for GLMD is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
- GLMD is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
86
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $59.12. The Score for CORT is 86, which is 72% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
GLMD Stock Price Chart
What is Galmed Pharmaceuticals's stock price today?
-
The Galmed Pharmaceuticals share price today is $2.88
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GLMD is experiencing slight buying pressure.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $59.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
GLMD Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.48 | Sell |
Relative Strength Index (14 RSI): | 37.24 | Sell |
Chaikin Money Flow: | 23812 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.2 - 4.18) | Sell |
Bollinger Bands (100): | (2.47 - 5.87) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.33 | Buy |
Relative Strength Index (14 RSI): | 78.53 | Buy |
Chaikin Money Flow: | 99396 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (45.14 - 52.96) | Buy |
Bollinger Bands (100): | (31.8 - 46.2) | Buy |
GLMD Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.15 | Sell |
20-day SMA: | 3.65 | Sell |
50-day SMA: | 4.73 | Sell |
200-day SMA: | 4.29 | Sell |
8-day EMA: | 3.17 | Sell |
20-day EMA: | 3.63 | Sell |
50-day EMA: | 4.16 | Sell |
200-day EMA: | 7.25 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.25 | Buy |
20-day SMA: | 49.96 | Buy |
50-day SMA: | 44.55 | Buy |
200-day SMA: | 32.18 | Buy |
8-day EMA: | 54.41 | Buy |
20-day EMA: | 50.72 | Buy |
50-day EMA: | 45.72 | Buy |
200-day EMA: | 35.55 | Buy |
Galmed Pharmaceuticals Earnings Growth & GLMD Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.70 per share, and an increase next year of $0.02 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.45 per share, and an increase next year of $0.39 per share.
Galmed Pharmaceuticals Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |